Key Summary:


  • Investment in digital health has slowed so far this year, however, experts are predicting that the development of tools for serious mental illness (SMI) will be a fruitful future direction for tech companies.
  • Chrissy Farr (Principal Investor and Health Tech Lead at OMERS Ventures) and Alyssa Jaffee (Partner at 7wireVentures) share their thoughts on why direct-to-consumer digital tools for SMI, such as eating disorders or obsessive-compulsive disorder, will lead the way in health technology investment.


Click here to read the full article.